Several lawsuits have recently been filed across the country alleging that Zofran, an antiemetic for blocking Seratonin caused severe child birth defects. An antiemetic is a drug used to prevent vomiting and nausea. In the cases filed, the mother was suffering from morning sickness and was prescribed Zofran. Zofran is the brand name for the drug Ondansetron, and is a 1991 FDA approved drug. The intended use of the drug is for patients who suffer from extreme nausea due to radiation therapy and treatment, and those who are suffering from nausea due to post-operative procedures. The FDA has never approved Zofran for treating morning sickness in pregnant women.
However, the maker of Zofran, GlaxoSmithKline (GSK), encouraged the use of the drug as an anti-nausea antidote for pregnant women afflicted with terrible morning sickness. There is evidence that GSK, did very little testing that would ensure the validity of their claim, of Zofran being a safe drug for use while pregnant. Various members of the medical community all over the world took it upon themselves to test the effects of Zofran usage while pregnant. The results of these tests showed a definite link of increased chances of child birth defects like cleft palate and congenital heart defects among others, in circumstances where Zofran was taken in the period of critical fetal development (first trimester). Read more about the studies here.
Child Birth Defect Figures in Indiana
The Indiana Birth Defects and Problems Registry (IBDPR) collects information on birth defects and birth problems for all children in Indiana from birth to 3 years old with the intention to determine the number of children born with birth defects, plan intervention and prevention strategies, and to offer resources to families. Indiana’s 2014 population estimate was 6,596,855. Of that figure, the estimated number of live child births that were birth defects is 3,600.
Child birth defects are relatively common and the causes of defects vary greatly from genetic to medical malpractice, to defective drugs. Our Zofran lawyers have assessed the state of Indiana to determine how many potential claims may exist based on epidemiological studies that suggest certain defect probabilities as a result of taking Zofran, the population, and birth rates in Indiana.
The figures of the five principal cities in Indiana are as follows:
- Indianapolis- population 843,393
- Fort Wayne- population 256,496
- Evansville- population 120,310
- South Bend- population 100,886
- Carmel- population 85,927
Estimations Of Cleft Palate Defects & Congenital Heart Abnormalities Connected To Zofran In Indiana
Based on the Indiana population of 6,596,855 we believe there maybe 720 births that are a kind of orofacial cleft, which is cleft palate / cleft lip and almost 2,880 congenital heart abnormalities, that were likely as a result of taking Zofran in the first three months of pregnancy. Based upon city populations in Indiana, these child birth defect statistics break down as follows:
- Indianapolis- 445 newborn birth defects with roughly 75 cleft palate, and 370 congenital heart abnormalities
- Fort Wayne- 170 newborn birth defects with roughly 24 cleft palate, and 146 congenital heart abnormalities
- Evansville- 110 newborn birth defects with roughly 15 cleft palate, and 95 congenital heart abnormalities
- South Bend- 97 newborn birth defects with roughly 9 cleft palate, and 88 congenital heart abnormalities
- Carmel- 90 newborn birth defects with roughly 8 cleft palate, and 82 congenital heart abnormalities
Adverse Effects & Birth Irregularities That Have Been Expressed
Although there have been a number of comparative medical studies conducted that have surmised Zofran intake while pregnant causes certain types of birth defects, Zofran creator GSK, refutes these claims. Also refer to our infographic for more details about an epidemiology study performed in the United States in 2012 that concluded that there was a 2.37 times greater chance of a baby being born with a cleft palate in instances where a mother used Zofran to alleviate morning sickness in the first 12 weeks of pregnancy versus mothers who did not take the drug. A lawsuit has already been filed by a family from Bilings Yellowstone, who can attest that their child was born with a cleft palate after the mother took Zofran for morning sickness in the early stages of her pregnancy. Read more about this lawsuit here. Other claims that have been filed against GSK, have seen claimants state that Zofran caused some of the following birth defects:
- Facial dysmorphia
- Kidney dysfunctions
- Club foot
- Low set ears
- Supraventricular tachycardia
- Congenital heart defects
- Cleft palate
- Cleft lip
Indiana Parents Pursuing Ways To File A Lawsuit
ZofranLegal.com is sponsored by several law firms so that the website is a source of relevant and up to date information about the Zofran case.Our legal team is not certified to practice law in Indiana, but we are certified to practice law in Delaware State where we also have offices. It should be noted that Delaware State is also the state where GSK has its headquarters. All in all Delaware is a viable state in which we could represent you in your Zofran claim. For our office location details click here.
You are likely have questions, so please call us. Our Zofran attorneys are here to speak with you 24/7. To meet our Zofran litigation team click here. When you come to us with your case we have several ways we advise you to file your case. We may see it fit that your claim be filed in Delaware, where we can represent you, or another applicable locale. Furthermore, we may see it fit for your case to be filed in Indiana utilizing the legal expertise of our trusted local legal counsel.